Currently only decomposed for meta-analysis of continuous or dichotomous data.
|
Competency A: Is it appropriate to combine these quantitative results? |
|
Subcompetency |
Justification |
Data Requirement |
|
1. Are the interventions comparable? |
What were the interventions? |
a. intervention description, as II.D.1.a |
|
Were there any co-interventions?
Co-interventions may confound the attributable effect of the experimental intervention |
b.i. co-intervention description, as II.E.2.a, and ii. co-intervention rates of use,
as II.E.2.c |
|
Were the interventions administered in such a way that any biases are comparable across the trials? |
c.i. completion of assigned treatment, as II.D.3.a, and ii. actual compliance, as II.D.3.b-d |
|
2. Are the study outcomes comparable? |
What were the study outcomes? |
a. outcome definitions, as II.F.1.a |
|
Were the study outcomes assessed in such a way that any biases are comparable across the trials?n |
b.i. outcome assessment methods, as II.G.1.a, and ii. personnel, as II.G.1.b |
|
3. Are the study populations comparable? |
Were the entrance criteria sufficiently similar to select similar groups of subjects? |
a. entrance criteria, as III.B.4.a-b |
|
Were the baseline characteristics of the subjects relatively similar? |
a. baseline characteristics, as III.B.4.c |
|
4. Are the study designs and executions comparable? |
Were the control groups similar? Differences in control groups affect the comparability of comparative
summary statistics (e.g., OR) |
a.i. description of control, as II.D.2.a, and ii. number of crossovers,
as II.D.3.d |
|
Were the settings of the studies sufficiently similar? Vastly different study settings or time of study can introduce unmatched confounders into the data synthesis |
b.i. sites, as III.C.1.a, and ii. when study conducted, as III.C.3.a-b |
|
Were the lengths of follow-up approximately the same? Different follow-up lengths can lead to essentially different outcomes |
c. actual follow-up time, as II.H.2.d |
|
Were the studies of similar quality? It is controversial how to adjust for trial quality (i.e., internal validity) in quantitative synthesis |
d. all data requirements for judging internal validity, as II.A-K |
|
Competency |
Method |
Method-Associated
Subcompetency |
Data |
Procedural |
|
B. Calculate summary statistic, for pairwise comparisons |
A. Odds Ratio (OR) |
1. Calculate OR
2. Calculate 95% confidence interval (ci) for OR |
a. complete 2 X 2 contingency table |
i. OR = a*d/b*c
ii. 95% ci formulas
iii. deduce 2*2 from necessary, sufficient data |
|
B. Relative Risk Reduction (RRR) |
1. Calculate RRR 2. Calculate 95% confidence interval (ci) for RRR |
a. as IV.B.1-2.a |
i. RRR = a/(a+b) c/(c+d)
ii. 95% ci formula |
|
C. Absolute Risk Reduction (ARR) |
1. Calculate ARR 2. Calculate 95% confidence interval (ci) for ARR |
a. as IV.B.1-2.a |
i. ARR = a/(a+b) - c/(c+d)
ii. 95% ci formula |
|
D. Number Needed to Treat (NNT) |
1. Calculate NNT |
a. ARR |
i. NNT= 1/ARR |
|
C. Quantitative meta-analysis |
A. MantelHaenszel, using odds ratio |
1. Calculate OR for each trial |
a. as IV.B.1-2.a |
i. as VI.B.1-2.a.i |
|
1. Calculate meta-analytic summary |
a. ORs for all the trials |
i. MantelHaenszel formula |